Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-26T00:15:48.312Z.
Calculation as of: 2026-09-26T00:15:48.312Z.
Quote observation: 2026-09-25T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d53bd5f3ae2a50c36c12dad7416524538d3c4f55d98f345e848307cf0610ae84
PEG RATIO
N/A
GSK plc
Market Cap
$98.65B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| GSK plc (GSK) | $98.65B | N/A |
| Sanofi (SNY)vs › | $98.71B | N/A |
| McKesson Corporation (MCK)vs › | $101.46B | N/A |
| HCA Healthcare, Inc. (HCA)vs › | $94.31B | N/A |
| Stryker Corporation (SYK)vs › | $104.41B | N/A |
| Elevance Health Inc. (ELV)vs › | $85.90B | N/A |
| Medtronic plc (MDT)vs › | $113.46B | N/A |
| CVS Health Corp. (CVS)vs › | $113.72B | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.19B | N/A |
| Moderna, Inc. (MRNA)vs › | $78.91B | N/A |
PEG Ratio
N/A
P/E Ratio
15.6
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
